Terconazole is an anti-fungal drug that is mainly used to treat vaginal yeast infections (or vaginal candidiasis). It is classified as a triazole ketal derivative. Terconazole was initially approved by the FDA in 1987. This drug is available in cream and suppository forms and both have demonstrated high levels of safety, efficacy, and tolerability in clinica...
For the treatment of candidiasis (a yeast-like fungal infection) of the vulva and vagina.
KO Clinical Research, LLC, Fort Lauderdale, Florida, United States
Women's Clinic of Lincoln, Lincoln, Nebraska, United States
Women's Clinical Research Center, Seattle, Washington, United States
Georgia Regents University, Augusta, Georgia, United States
Mount Vernon CLinical Research, Sandy Springs, Georgia, United States
Women's Health Practice, Champaign, Illinois, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.